Linarin Reverses Doxorubicin Resistance by Modulating PTEN and MDR1 Expression in MCF-7 Breast Cancer Cells
Introduction: Chemoresistance in breast cancer remains a major obstacle that limits the effectiveness of current therapeutic options for patients. Therefore, the identification or development of adjuvant compounds with minimal side effects to enhance the efficacy of standard treatments continues to be an important goal...